3C-MAL

3C-MAL, also known as 4-methylallyloxy-3,5-dimethoxyamphetamine or as α-methylmethallylescaline, is a chemical compound of the phenethylamine, amphetamine, and 3C families related to the psychedelic drug 3,4,5-trimethoxyamphetamine. It is the amphetamine analogue of the psychedelic methallylescaline. The compound does not appear to have been tested in humans, and its dose, duration, and effects are unknown. Its chemical synthesis has been described. 3C-MAL was first described in the scientific literature by Daniel Trachsel in 2002. It is a controlled substance in Canada under phenethylamine blanket-ban language.